Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma
Clinical trial NCT03730740 · UNKNOWN
Trial details
- NCT number
- NCT03730740
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-16
- Primary completion
- 2021-11-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.